Global Vaccine and Immunization Research Forum (GVIRF)

February 22, 2021 - February 25, 2021

The Global Vaccine and Immunization Research Forum (GVIRF) is a global meeting that brings together the entire Vaccine and Immunization Research community, from basic immunology to implementation research, and from low to high income countries. It is hosted every two years by World Health Organization, the US National Institutes of Health, and the Bill & Melinda Gates Foundation.

GVIRF will:

  1. Track progress in vaccine research and development
  2. Identify gapsopportunities and actions to maximize the benefit of immunization
  3. Foster networking and collaboration to accelerate progress
  4. Support implementation of Immunization Agenda 2030

To enable active participation regardless of time zone, GVIRF 2021 will be held twice each day. The first block is for participants closer to the prime meridian (UTC +0). The second block is for participants closer to the international date line (UTC +12). Both blocks will have the same content. Please attend the sessions that work best for you.

GVIRF is hosted every two years by World Health Organization, the US National Institutes of Health, and the Bill & Melinda Gates Foundation.

View the agenda and find out more information on how to attend the forum here.

You May Also Like

VPPN Market Intelligence Series: Europe and Central Asia countries tell us how they leverage market intelligence for their vaccine procurement strategy

The Vaccine Procurement Practitioners Network (VPPN) will conclude their series on market intelligence with a third and final webinar that will take place on Thursday, 5 December 2024, from 1pm to 2pm GMT+1, in English, Russian and French. This webinar will focus on how market intelligence can help with understanding vaccine markets to inform a procurement … Read More

2025 Advanced Course of Vaccinology (ADVAC)

ADVAC is a two-week training program which delivers a comprehensive overview of the various aspects of vaccinology. This advanced Course is for scientists and decision-makers involved in vaccine development, in the elaboration of new vaccination strategies or in policy decisions related to the introduction of new vaccines in public health programmes, at national or international … Read More